Trial Profile
A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs GHRP 1 (Primary)
- Indications Kidney disorders
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Novelion Therapeutics
- 27 May 2014 New trial record